ClinicalTrials.gg
CompletedNCT00813683Updated Dec 22, 2025

Cephalic Version by Acupuncture for Breech Presentation

An interventional study of Acupuncture stimulation and Acupuncture stimulation in Breech Presentation, sponsored by University Hospital, Strasbourg, France. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by University Hospital, Strasbourg, France · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
259
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

We want to study the efficiency of acupuncture for cephalic version of breech presentation during pregnancy.

Several randomized studies show that acupuncture may be useful in version of breech presentation, but none with a sham.

Protocol :

  • Inclusion of patients with fetus in breech presentation at 32-34 weeks of pregnancy.
  • Randomization. First group : acupuncture by stimulation of "67 Bladder" point.Second group : stimulation of "45 Stomach" point (sham).
  • Ultrasonographic control of presentation at 35 weeks.
02

Conditions studied

  • Breech Presentation

Browse trials for

Keywords

  • Acupuncture, moxybustion,
  • Cephalic version,
  • Breech presentation
03

In context

Breech Presentation

41 studies on the registry are indexed under Breech Presentation; 10 are open to participants now.

This study's enrollment of 259 is above the median of 119 across 31 interventional studies indexed under Breech Presentation.

Browse Breech Presentation studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Single pregnancy at 32-34 weeks of pregnancy.
  • Fetus in breech presentation.

Exclusion criteria

Exclusion criteria:

  • Twins.
  • Story of preterm birth or any preterm birth risk
  • Fetal malformations, abnormal karyotype
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
259 participants (actual)

Study arms

  • Experimental
    1

    Stimulation of "67 Bladder" point

    Other: Acupuncture stimulation

  • Sham comparator
    2

    Stimulation of "45 Stomach" point (sham)

    Other: Acupuncture stimulation

Interventions

  • OtherAcupuncture stimulation

    Acupuncture by stimulation of "67 Bladder" point

  • OtherAcupuncture stimulation

    Acupuncture stimulation of "45 Stomach" point (sham)

06

What researchers measure

Primary outcomes

  1. Cephalic or breech presentation (ultrasonographic control at 35 weeks of pregnancy)

    Time frame: 35 weeks

Secondary outcomes

  1. general outcomes about external cephalic version, delivery and neonates

    Time frame: 35 weeks

07

Study locations

1 site
  • Service de Gynécologie-Obstétrique, Hôpital SIHCUS - CMCO, 19 rue Louis Pasteur
    Schiltigheim, 67303, France
08

References and documents

Publications

  • Sananes N, Roth GE, Aissi GA, Meyer N, Bigler A, Bouschbacher JM, Helmlinger C, Viville B, Guilpain M, Gaudineau A, Akladios CY, Nisand I, Langer B, Vayssiere C, Favre R. Acupuncture version of breech presentation: a randomized sham-controlled single-blinded trial. Eur J Obstet Gynecol Reprod Biol. 2016 Sep;204:24-30. doi: 10.1016/j.ejogrb.2016.07.492. Epub 2016 Aug 2. PubMed 27521594 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00813683
Responsible party
Sponsor
First posted
Dec 23, 2008
Start date
Feb 2008
Primary completion
May 2014
Completion
May 2014
Last update
Dec 22, 2025

Study contacts

Romain FAVRE, MD
principal investigator · Hôpitaux Universitaires de Strasbourg

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion